Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly E Dunn

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 18, 2015
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking CessationKelly E Dunn, Taylor F Marcus, Cynthia Kim, et al.
Addictive Behaviors|December 17, 2008
Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot studyStacey C Sigmon, Kelly E Dunn, Gary J Badger, et al.
Drug and Alcohol Dependence|February 8, 2020
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemicAlbert Garcia-Romeu, David J Cox, Kirsten E Smith, et al.
Experimental and Clinical Psychopharmacology|February 5, 2014
Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patientsKelly E Dunn, Michael Fingerhood, Conrad J Wong, et al.
JAMA Network Open|March 15, 2023
Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical TrialOrrin D Ware, Mary M Sweeney, Colin Cunningham, et al.
Addiction (Abingdon, England)|July 10, 2024
Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorderRamin Mojtabai, Ryoko Susukida, Mehdi Farokhnia, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2019
Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human EvidenceKelly E Dunn, Andrew S Huhn, Cecilia L Bergeria, et al.
Journal of Substance Abuse Treatment|August 31, 2013
Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalitiesErin A McClure, Shauna P Acquavita, Kelly E Dunn, et al.
Drug and Alcohol Dependence|May 30, 2021
The continued rise of methamphetamine use among people who use heroin in the United StatesJustin C Strickland, William W Stoops, Kelly E Dunn, et al.
The American Journal on Addictions|February 28, 2025
Case Series: Magnitude and duration of fentanyl and xylazine detection in the urine of persons with opioid use disorderHelen E Bird, William A Clarke, Craig W Hendrix, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 18, 2015
Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking CessationKelly E Dunn, Taylor F Marcus, Cynthia Kim, et al.
Addictive Behaviors|December 17, 2008
Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot studyStacey C Sigmon, Kelly E Dunn, Gary J Badger, et al.
Drug and Alcohol Dependence|February 8, 2020
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemicAlbert Garcia-Romeu, David J Cox, Kirsten E Smith, et al.
Experimental and Clinical Psychopharmacology|February 5, 2014
Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patientsKelly E Dunn, Michael Fingerhood, Conrad J Wong, et al.
JAMA Network Open|March 15, 2023
Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical TrialOrrin D Ware, Mary M Sweeney, Colin Cunningham, et al.
Addiction (Abingdon, England)|July 10, 2024
Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorderRamin Mojtabai, Ryoko Susukida, Mehdi Farokhnia, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2019
Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human EvidenceKelly E Dunn, Andrew S Huhn, Cecilia L Bergeria, et al.
Journal of Substance Abuse Treatment|August 31, 2013
Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalitiesErin A McClure, Shauna P Acquavita, Kelly E Dunn, et al.
Drug and Alcohol Dependence|May 30, 2021
The continued rise of methamphetamine use among people who use heroin in the United StatesJustin C Strickland, William W Stoops, Kelly E Dunn, et al.
The American Journal on Addictions|February 28, 2025
Case Series: Magnitude and duration of fentanyl and xylazine detection in the urine of persons with opioid use disorderHelen E Bird, William A Clarke, Craig W Hendrix, et al.
Pageof 17